T7 RNA polymerase is the workhorse of in vitro transcription: a single-subunit enzyme from bacteriophage T7 that initiates at its own promoter sequence and needs nothing else to make RNA from a DNA template. It is what sits behind a guide RNA made in-house, a labeled probe, a self-amplifying construct and every messenger RNA process at any scale. Buying it looks like buying a catalog reagent until the volumes rise, at which point grade, unit definition and supply become the whole question.
What the enzyme does, and why the promoter matters
The polymerase recognizes a short double-stranded promoter and transcribes downstream of it, which is why the template rather than the enzyme usually decides the outcome. A linear template cut cleanly at the end of the sequence gives a defined product; a nicked or incompletely digested plasmid gives a population of lengths. The enzyme is also happy to add untemplated bases at the end and to copy the product back on itself, which is the origin of much of the double-stranded RNA that downstream processes then have to remove. None of that is a defect in the enzyme lot: it is the chemistry, and it is why the specification of the template belongs in the same conversation as the specification of the enzyme.
Grades, units and what a unit actually measures
A unit of T7 RNA polymerase is defined by each supplier against its own assay, typically the incorporation of a nucleotide into acid-insoluble product per minute at a stated temperature on a stated template. Two enzymes quoted at the same units per microlitre are therefore not necessarily interchangeable, and the comparison that matters is yield of your product from your template under your conditions. Concentration, glycerol content and storage buffer affect how the enzyme behaves in a large reaction rather than a tube, and a high-concentration format is worth paying for once the reaction volume stops being a laboratory volume.
Mutant and thermostable variants
Engineered variants exist for specific problems: higher thermostability so the reaction can run hotter and the template stay linear, altered nucleotide selectivity for modified bases, and mutants that produce less double-stranded by-product. Each trades something, usually absolute yield or cost. Choose the variant by the problem you actually have, and be sceptical of a claim that a variant fixes by-product formation without a measurement on a template like yours, because the by-product depends on the sequence at the end of the template as much as on the enzyme.
Buying for t7 in vitro transcription at scale
At scale the questions are supply rather than catalog: lot size, lot-to-lot consistency data, whether the supplier will reserve material, and whether an animal-origin-free and later a compliant manufacturing grade exists in the same product line so a process does not have to be re-developed when it moves. If the product is destined for clinical material the relevant framework is the manufacturing and control expectation for the therapy, not the enzyme's research specification, and the documentation the supplier can provide becomes a selection criterion in its own right.
A t7 promoter plasmid, and what it needs to work
A T7 promoter is not read by a bacterium's own polymerase, which is the point of it: transcription happens only where T7 RNA polymerase is supplied, so an expression host carries the polymerase gene under an inducible promoter, or the plasmid is used in vitro with purified enzyme. That gives tight control and very high transcription rates, and it brings the failure modes with it: basal expression from leaky induction, plasmid instability with a toxic product, and in vitro transcription that needs the template linearised and the template's own end sequence considered.
A phic31 integrase and site specific integration
phiC31 integrase inserts a donor at a pseudo site in the genome, which gives a defined single copy integration rather than the random pattern a transposon gives, at the cost of fewer available sites and a species dependent efficiency. What a laboratory records is which pseudo site was used, since expression varies between them as much as between random integrations.
crispr lentivirus and what the vector carries
A crispr lentivirus delivers the guide, the nuclease, or both, and the choice changes the titre and the timeline: an all in one vector is convenient and large, while separate vectors allow a stable nuclease line and a guide library on top. Multiplicity of infection sets the editing and the toxicity, and a functional titre rather than a particle count is what makes the dose reproducible.
A lentiviral construct and the elements to check
A lentiviral construct is read for its promoter, its selection marker, whether it is self inactivating and how large the insert is, because packaging efficiency falls sharply with size. A map and a full sequence are what allow a titre problem to be diagnosed later. Biosafety level follows the envelope and the insert rather than the vector's name.
A lentivirus plasmid and the system around it
A lentivirus plasmid alone makes nothing: the transfer vector needs packaging and envelope plasmids of the same generation, and mixing generations is a documented way to get no virus. Third generation systems split the functions further for containment. The combination used is what a laboratory records, because the risk assessment follows it rather than the insert alone.
aav vector production and the scale question
aav vector production at research scale is transient transfection of a triple plasmid set followed by a capture step, and the yield per cell rather than the volume is what limits it. The measurements that matter are genome titre after nuclease treatment and the full to empty capsid ratio. Moving to a larger scale changes the purification rather than the transfection.
Questions people ask about t7 rna polymerase
What is a unit of T7 RNA polymerase?
An activity defined by the supplier's own incorporation assay, not an international standard. Compare enzymes on RNA yield from your own template rather than on units per microlitre.
Do I need a GMP grade enzyme?
Only if the RNA is destined for material given to a person or an animal in a regulated study. For research and process development a high-quality research grade is the right purchase, provided the supplier offers a compliant grade in the same line for later.
Why is my in vitro transcription yield low?
Usually the template rather than the enzyme: incomplete linearisation, a truncated or damaged promoter, contaminating nuclease, or magnesium and nucleotide concentrations out of balance. Check the template on a gel before buying a different enzyme.